Pharmaceutical

Fresenius Kabi and Cellular Origins agree CGT manufacture automation

Fresenius Kabi and Cellular Origins have announced a partnership to advance cell and gene therapy (CGT) by automating manufacturing.

Oct 18, 2024 - 04:00
Fresenius Kabi and Cellular Origins agree CGT manufacture automation
Fresenius Kabi and Cellular Origins have announced a partnership to advance cell and gene therapy (CGT) by automating manufacturing.
Read the original article

Tags:

Previous Article

Bavarian Nordic’s mpox vaccine equally effective in teens as adults

Next Article

Glaukos eyes FDA approval for ocular therapy after Phase III win

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

AI boom set to revolutionise healthcare in Europe

AI boom set to revolutionise healthcare in Europe

Sep 22, 2024

Opinion: Your health insurance may not be as good your state requires — and it’s perfectly legal

Opinion: Your health insurance may not be as good your ...

Jun 10, 2023

Samyang and LG Chem partner to develop new mRNA-based cancer therapeutics

Samyang and LG Chem partner to develop new mRNA-based c...

Apr 22, 2023